Inhibitors of HIF Prolyl Hydroxylases

Annual Reports in Medicinal Chemistry

Volumn 45, Issue C, 2010, Pages 123-139

  Rabinowitz, Michael H ^a   Barrett, Terrance D ^a   Rosen, Mark D ^a   Venkatesan, Hariharan ^a  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957761392     PISSN: 00657743     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-7743(10)45008-3     Document Type: Book

References (70)

1. Wang G.L., Jiang B.H., Rue E.A., Semenza G.L. Proc. Natl. Acad. Sci. USA 1995, 92:5510.
2. Semenza G.L., Wang G.L. Mol. Cell. Biol. 1992, 12:5447.
3. Ivan M., Kondo K., Yang H., Kim W., Valiando J., Ohh M., Salic A., Asara J.M., Lane W.S., Kaelin W.G. Science 2001, 292:464.
4. Jaakkola P., Mole D.R., Tian Y.M., Wilson M.I., Gielbert J., Gaskell S.J., Kriegsheim A.V., Hebestreit H.F., Mukherji M., Schofield S.J., Maxwell P.H., Pugh C.W., Ratcliffe P.J. Science 2001, 292:468.
5. Bruick R.K., McKnight S.L. Science 2001, 294:1337.
6. Epstein A.C.R., Gleadle J.M., McNeill L.A., Hewitson K.S., O'Rourke J., Mole D.R., Mukherji M., Metzen E., Wilson M.I., Dhanda A., Tian Y.-M., Masson N., Hamilton D.L., Jaakkola P., Barstead R., Hodgkin J., Maxwell P.H., Pugh C.W., Schofield C.J., Ratcliffe P.J. Cell 2001, 107:43.
7. Hirsila M., Koivunen P., Gunzler V., Kivirikko K.I., Myllyharju J. J. Biol. Chem. 2003, 33:30772.
8. Percy M.J., Furlow P.W., Beer P.A., Lappin T.R., McMullin M.F., Lee F.S. Blood 2007, 112:2193.
9. Hu C.J., Sataur A., Wang L., Chen H., Simon M.C. Mol Biol Cell 2007, 18:4528.
10. Metzen E., Berchner-Pfannschmidt U., Stengel P., Marxsen J.H., Stolze I., Klinger M., Huang W.Q., Wotzlaw C., Hellwig-Bürgel T., Jelkmann W., Acker H., Fandrey J. J Cell Sci. 2003, 116:1319.
11. Berra E., Benizri E., Ginouvès A., Volmat V., Roux D., Pouysségur J. EMBO J. 2003, 22:4082.
12. Takeda K., Ho V.C., Takeda H., Duan L.J., Nagy A., Fong G.H. Mol. Cell. Biol. 2006, 26:8336.
13. Takeda K., Cowan A., Fong G.H. Circulation 2007, 116:774.
14. Takeda K., Aguila H.L., Parikh N.S., Li X., Lamothe K., Duan L.J., Takeda H., Lee F.S., Fong G.H. Blood 2008, 111:3229.
15. Purpero V., Morton G.R. J. Biol. Inorg. Chem. 2007, 12:587.
16. Bruijnincx P.C.A., van Koten G., Klein Gebbink R.J.M. Chem. Soc. Rev. 2008, 37:2716.
17. McDonough M.A., Li V., Flashman E., Rasheduzzaman C., Mohr C., Lienard B.M.R., Zondlo J., Oldham N.J., Clifton I.J., Lewis J., McNeill L.A., Kurzeja R.J.M., Hewitson K.S., Yang E., Jordan S., Syed R.S., Schofield C.J. Proc. Natl. Acad. Sci. USA 2006, 103:9814.
18. A. G. Evodkimov, R. L. Walter, M. Mekel, M. E. Pokross, R. Kawamoto, and A. Boyer, 2006, RCSB protein data bank ID: 2HBT.
19. Poppe L., Tegley C.M., Li V., Lewis J., Zondlo J., Yang E., Kurzeja R.J.M., Syed R. J. Am. Chem. Soc. 2009, 131:16654.
20. Wang G.L., Semenza G.L. Blood 1993, 82:3610.
21. Tan T., Luciano J.A., Scholz P.M., Weiss H.R. Clin. Exp. Pharmacol. Physiol. 2009, 36:904.
22. Thangarajah H., Vial I.N., Grogan R.H., Yao D., Shi Y., Januszyk M., Galiano R.D., Chang E.I., Galvez M.G., Glotzbach J.P., Wong V.W., Brownlee M., Gurtner G.C. Cell Cycle 2010, 9:75.
23. Thangarajah H., Yao D., Chang E.I., Shi Y., Jazayeri L., Vial I.N., Galiano R.D., Du X.-L., Grogan R., Galvez M.G., Januszyk M., Brownlee M., Gurtner G.C. Proc. Nat. Acad. Sci. USA 2009, 106:13505.
24. Dongiovanni P., Valenti L., Fracanzani A.L., Gatti S., Cairo G., Fargion S. Am. J. Pathol. 2008, 172:738.
25. Gunton J. Patent Application WO 2009/086592 2009.
26. Lee D.W., Rajagopalan S., Siddiq A., Gwiazda R., Yang L., Beal M.F., Ratan R.R., Andersen J.K. J. Biol. Chem. 2009, 284:29065.
27. Ttriantafyllou A., Mylonis I., Simos G., Bonanou S., Tsakalof A. Free Radical Biol. Med. 2007, 44:657.
28. Park S.-S., Bae I., Lee Y.J. J. Cell. Biochem. 2008, 103:1989.
29. Shui Y.-B., Arbeit J.M., Johnson R.S., Beebe D.C. Invest. Opthal. Vis. Sci. 2008, 49:4961.
30. Xia M., Huang R., Sun Y., Semenza G.L., Aldred S.F., Witt K.L., Inglese J., Tice R.R., Austin C.P. Toxicol. Sci. 2009, 112:153.
31. Banerji B., Conejo-Garcia A., McNeill L.A., McDonough M.A., Buck M.R.G., Hewitson K.S., Oldham N.J., Schofield C.J. Chem. Commun. 2005, 43:5438.
32. Rosen M.D., Venkatesan H., Peltier H.M., Bembenek S.D., Barrett T.D., Kanelakis K.C., Zhao L.X., Leonard B., Hocutt F.M., Wu X., Palomino H.L., Brondstetter T.I., Haug P.V., Cagnon L., Yan W., Liotta L.A., Young A., Mirzadegan T., Shankley N.P., Rabinowitz M.H. Med. Chem. Lett. 2010, (submitted for publication).
33. Gotchev D.B., Jin J., Wang Y. Patent Application WO 2009/086044-A1 2009.
34. Thede K., Flamme I., Oehme F., Ergueden J.-K., Stoll F., Schuhmacher J., Wild H., Kolkhof P., Beck H., Keldenich J., Akbaba M., Jeske M. Patent Application WO 2008/067871-A1 2008.
35. Jeske M., Flamme I., Stoll F., Oehme F. Patent Application DE 102007/048447 2009.
36. Jeske M., Flamme I., Stoll F., Oehme F., Akbaba M. Patent Application DE 2007/102007049157 2007.
37. Clements M.J., Debenham J.S., Hale J.J., Madsen-Duggan C.B., Walsh T.F. Patent Application WO 2009/117269 2009.
38. Cunliffe C.J., Franklin T.J., Hales N.J., Hill G.B. J. Med. Chem. 1992, 35:2652.
39. Franklin T.J., Hales N.J., Johnstone D., Morris W.B., Cunliffe C.J., Millest A.J., Hill G.B. Biochem. Soc. Trans. 1991, 19:812.
40. Weidmann K., Baringhaus K.-H., Tschank G., Werner U. Patent Application DE 19746287-A1 1999.
41. Arend M.P., Flippin L.A., Guenzler-Pukall V., Ho W.-B., Turtle E.D., Du X. Patent Application WO 2004/108681-A1 2004.
42. Arend M.P., Flippin L.A., Wu M., Turtle E.D., Ho W.-B., Deng S. Patent Application WO 2007/090068-A2 2007.
43. Turtle E.D., Flippin L.A., Arend M.P., Cheng H. Patent Application US 2006/199836-A1 2006.
44. Deng S., Wu M., Turtle E.D., Ho W.-B., Arend M.P., Cheng H., Flippin L.A. Patent Application WO 2007/115315-A2 2007.
45. Arend M.P., Cheng H., Flippin L.A., Ng D., Turtle E., Wu M. Patent Application WO 2009/073669-A1 2009.
46. Zhou X., Arend M.P., Wu M., Flippin L.A. Patent Application WO 2009/089547-A1 2009.
47. Warshakoon N.C., Wu S., Boyer A., Kawamoto R., Sheville J., Bhatt R.T., Renock S., Xu K., Pokross M., Zhou S., Walter R., Mekel M., Evdokimov A.G., East S. Bioorg. Med. Chem. Lett. 2006, 16:5616.
48. Kawamoto R.M. Patent Application US 2007/299086-A1 2007.
49. Chai D., Colon M., Duffy K.J., Fitch D.M., Tedesco R., Zimmerman M.N. Patent Application WO 2007/038571-A2 2007.
50. Allen J.R., Burli R., Bryan M.C., Cao G.-Q., Neira S.C., Reed A.B. Patent Application WO 2008/130600-A2 2008.
51. Guiadeen D., Hale J.J., Kothandaraman S. Patent Application WO 2008/130527-A1 2008.
52. Allen J.R., Biswas K., Burli R., Golden J.E., Mercede S., Tegley C.M. Patent Application WO 2008/137084-A2 2008.
53. Fitch D.M., Colon M. Patent Application WO 2007/103905-A2 2007.
54. Fitch D.M., Chai D. Patent Application WO 2007/136990-A2 2007.
55. Allen J.R., Burli R., Frohn M.J., Hungate R.W., Neira S.C., Reed A.B. Patent Application WO 2008/137060-A1 2008.
56. Frohn M., Viswanadhan V., Pickrell A.J., Golden J.E., Muller K.M., Buerli R.W., Biddlecome G., Yoder S.C., Rogers N., Dao J.H., Hungate R., Allen J.R. Bioorg. Med. Chem. Lett. 2008, 18:5023.
57. Colandrea V.J., Hale J.J., McCoy J.G. Patent Application WO 2009/108496-A1 2009.
58. Clements M.J., Colandrea V.J., Debenham J.S., Hale J.J., Madsen-Duggan C.B., Walsh T.F. Patent Application WO 2009/108499-A1 2009.
59. Debenham J.S., Hale J.J., Madsen-Duggan C.B., Walsh T.F. Patent Application WO 2009/108497-A1 2009.
60. Shaw A.N., Duffy K.J., Miller W.H., Myers A.K., Zimmerman M.N. Patent Application WO 2008/089052-A2 2008.
61. Shaw A.N., Duffy K.J., Tedesco R., Wiggall K. Patent Application US 2008/171756-A1 2008.
62. Duffy K.J., Fitch D.M., Jin J., Liu R., Shaw A.N., Wiggall K. Patent Application WO 2007/150011-A2 2007.
63. Warshakoon N.C., Wu S., Boyer A., Kawamoto R., Renock S., Xu K., Pokross M., Evdokimov A.G., Zhou S., Winter C., Walter R., Mekel M. Bioorg. Med. Chem. Lett. 2006, 16:5687.
64. Hocutt F.M., Leonard B.E., Peltier H.M., Phuong V.K., Rabinowitz M.H., Rosen M.D., Tarantino K.T., Venkatesan H., Zhao L.X. Patent Application WO 2009/134750 2009.
65. Tegley C.M., Viswanadhan V.N., Biswas K., Frohn M.J., Peterkin T.A.N., Chang C., Buerli R.W., Dao J.H., Veith H., Rogers N., Yoder S.C., Biddlecome G., Tagari P., Allen J.R., Hungate R.W. Bioorg. Med. Chem. Lett. 2008, 18:3925.
66. Klaus S.J., Neff T.B. Patent Application US 2006/0276477-A1 2006.
67. P. Frohna, S. Milwee, J. Pinkett, T. Lee, K. Moore-Perry, J. Chou, and R. H. Ellison in Results from a Randomized, Single-Blind, Placebo-Controlled Trial of FG-4592, a Novel Hypoxia Inducible Factor Prolyl Hydroxylase Inhibitor, in CKD Anemia, Vol. 2007, American Society of Nephrology Renal Week, San Francisco, November 2-5, 2007, Abstract SU-PO806, as abstracted in N. Agarwal and J. T. Prchal, Semin. Hematol., 2008, 45, 267.
68. The FDA Accepts the Complete Response for Clinical Hold of FG-2216/FG-4592 for the Treatment of Anemia, April 2, 2008, (accessed July 6, 2010). http://www.astellas.com/en/corporate/news/pdf/080402%5Feg.pdf.
69. Repeat Dose Safety Study for Compound to Treat Anemia, November 11, 2009, http://clinicaltrials.gov/show/NCT00840320 (accessed July 6, 2010).
70. Akebia Announce Positive Results for AKB-6548 Phase 1 Clinical Study, January 5, 2010, (accessed July 6, 2010). http://www.akebia.com/AKB6548%5FPhase%5F1a%5FCompletion.pdf.